Heartflow, Inc. stocks have been trading up by 9.63 percent after positive sentiment around its advanced cardiac imaging technology.
Click Here for a Millionaire's POV on Trading HTFL
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
What Traders Need To Know
- Shares ripped higher, surging as much as 33% after Heartflow, Inc. posted a narrower Q2 non-GAAP loss on higher revenue and raised its 2026 revenue outlook.
- Strong upside move signals traders are rewarding both the earnings surprise and management’s confidence in longer-term growth.
- Intraday action showed a wide range day, with HTFL spiking from the low $46 area to above $50 before closing just under $50.
- Weekly candles now show a sharp bullish reversal, with HTFL reclaiming recent levels after the earnings-driven rally.
Weekly Update Sep 07 – Sep 11, 2026: On Saturday, September 12, 2026 Heartflow, Inc. stock [NASDAQ: HTFL] is trending up by 9.63%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Healthcare industry expert:
Analyst sentiment – positive
HeartFlow (HTFL) occupies a differentiated niche in non-invasive cardiac diagnostics, with strong 80% gross margins indicating attractive unit economics despite deeply negative EBIT margin (~-54%) and ROA (-32%). Revenue of ~$176M on an enterprise value of ~$4.2B embeds a rich EV/sales multiple versus Healthcare Providers & Services peers, which generally trade lower but are profitable. Liquidity is robust (current ratio 5.1, quick ratio 4.7, minimal leverage), though persistent losses and negative free cash flow (-$10.5M in Q2) highlight ongoing funding needs.
Technically, HTFL is short-term bullish with a sharp rebound from the mid-40s to ~50, forming a strong weekly range between $44.88 support and $50.40 resistance. The push to new local highs on elevated volume after earnings indicates aggressive dip-buying and limited supply near recent lows. Intraday 5-minute action shows buyers defending the $47–48 zone repeatedly. A defined trading level is $47: above it, long bias with stops near $45.40; a weekly close below $47 would signal momentum exhaustion.
More Breaking News
- Nebius Group NBIS Soars After Palantir AI Partnership
- KXIN Stock Slides As Volatility Grips Kaixin Holdings
- FLNC Stock Slides As Guidance Slashed And Wall Street Turns Bearish
- TURB Stock Pops On Volatile Spike As Traders Zero In
Recent news catalysts are clearly supportive: a narrower Q2 non-GAAP loss, higher revenue, and raised 2026 revenue outlook triggered 24–33% share price spikes, reflecting strong institutional interest. Relative to Healthcare and Providers & Services benchmarks, HTFL trades as a high-growth, high-loss outlier but with superior margins and a cleaner balance sheet. Base case: continued multiple support while execution improves. Near-term support sits at $47, resistance at $52–53; 6–12 month upside skew favors a $55–60 target.
Quick Financial Overview
Heartflow, Inc. sits in a classic high-growth, high-loss profile. Revenue for the recent period is about $176.0M, with quarterly revenue near $64.1M and gross margin around 80.1%. That strong margin tells traders the core product has solid pricing power, but the company is still deep in the red, with an EBIT margin of about -54.2% and profit margin close to -55.8%.
On the balance sheet, HTFL carries total assets of roughly $344.5M and equity near $279.7M, with modest total liabilities of about $64.7M. Cash and short-term investments are sizable around $162.6M, backing a current ratio of 5.1 and a quick ratio of 4.7. Debt looks manageable, with total debt-to-equity of only 0.1 and long-term debt of about $20.3M, which is important for a loss-making name.
Cash flow is still negative from operations at about -$8.6M for the quarter, and free cash flow is roughly -$10.5M, so dilution and cash burn remain key watchpoints. The Q2 income statement shows a net loss of about $15.7M, or -$0.18 per share, but traders just rewarded the fact that this loss came in narrower than expected, alongside revenue growth. On the chart, weekly data show HTFL bouncing from the mid-$40s toward $50, while the intraday candle reveals a powerful expansion day from about $46.1 to a high near $50.2 before closing strong.
Conclusion
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.